High Plasma Aldosterone Levels on Admission Are Associated With Death in Patients Presenting With Acute ST-Elevation Myocardial Infarction | Zendy

Farzin Beygui | Zendy; JeanPhilippe Collet | Zendy; JeanJacques Benoliel | Zendy; Nicolas Vignolles | Zendy; Raphaëlle Dumaine | Zendy; Olivier Barthélémy | Zendy; Gilles Montalescot | Zendy

Open Access

High Plasma Aldosterone Levels on Admission Are Associated With Death in Patients Presenting With Acute ST-Elevation Myocardial Infarction

Author(s) -

Farzin Beygui,

JeanPhilippe Collet,

JeanJacques Benoliel,

Nicolas Vignolles,

Raphaëlle Dumaine,

Olivier Barthélémy,

Gilles Montalescot

Publication year - 2006

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.106.634626

Subject(s) - medicine , aldosterone , myocardial infarction , cardiology , killip class , percutaneous coronary intervention , hazard ratio , heart failure , quartile , confidence interval

Aldosterone, the final mediator of the renin-angiotensin-aldosterone pathway, is at its highest plasma levels at presentation for ST-elevation myocardial infarction (STEMI). Whether aldosterone level at presentation for STEMI is associated with adverse outcome remains unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research